February 06, 2026
The Patent Trial and Appeal Board has found that Geneoscopy had shown that all the claims it challenged in a patent on Exact Sciences' colon cancer test Cologuard are invalid as obvious, months after the PTAB invalidated claims in a similar patent.
November 17, 2023
Exact Sciences Corp. filed an infringement suit against Geneoscopy Inc., claiming that its competitor infringed a patent covering its Cologuard stool DNA-based colorectal cancer screening test and asked the court to block the competing test from hitting the market.